Apellis Pharmaceuticals (APLS) Receivables - Other (2022 - 2025)
Historic Receivables - Other for Apellis Pharmaceuticals (APLS) over the last 4 years, with Q3 2025 value amounting to $6.5 million.
- Apellis Pharmaceuticals' Receivables - Other rose 3178.7% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 3178.7%. This contributed to the annual value of $4.5 million for FY2024, which is 4816.63% up from last year.
- Apellis Pharmaceuticals' Receivables - Other amounted to $6.5 million in Q3 2025, which was up 3178.7% from $5.9 million recorded in Q2 2025.
- Apellis Pharmaceuticals' Receivables - Other's 5-year high stood at $6.5 million during Q3 2025, with a 5-year trough of $1.4 million in Q4 2022.
- In the last 4 years, Apellis Pharmaceuticals' Receivables - Other had a median value of $4.5 million in 2024 and averaged $4.0 million.
- Per our database at Business Quant, Apellis Pharmaceuticals' Receivables - Other skyrocketed by 18171.57% in 2024 and then skyrocketed by 3178.7% in 2025.
- Quarter analysis of 4 years shows Apellis Pharmaceuticals' Receivables - Other stood at $1.4 million in 2022, then skyrocketed by 111.79% to $3.1 million in 2023, then skyrocketed by 48.17% to $4.5 million in 2024, then soared by 44.4% to $6.5 million in 2025.
- Its last three reported values are $6.5 million in Q3 2025, $5.9 million for Q2 2025, and $6.1 million during Q1 2025.